The result of colonization of wounds by multiple-resistant organisms is usually an extremley long treatment process often leading to amputations in order to prevent a possible sepsis.
When it comes to the patient, quite often it isn´t only the wound itself or the healing process that cause discomfort. There are other drawbacks and side effects of chronic wounds such as pain,
odor and exudates.
These can often lead to both, mobility and activity reduction, thus putting a great constraint on the
PATHELEN® significantly improves the quality of life of any patient due to its great sorption activity which results in the binding of toxic substances and a reduced level of necrotic tissue in the wound thus reducing typical side effects of wound infections.
In Germany die between
15,000 to 40,000 people (statistics are not unique to) p.a. only to MRSA infections
and there are more and more new problem bacteria which are
hard to get under control. The number of patients with chronic
wounds in Germany alone amounts to 4 million.
In the field of the DFS annual 40,000 amputations are necessary. The mortality rate here is after 2 years at about 40%.